Mederi
Mederi is a Tokyo-based FemTech company offering online pill prescriptions and obstetrician-gynecologist consultations through a LINE-native telemedicine platform, serving Japanese women with discreet subscription-based hormonal contraceptives and menstrual health treatments across 15 formulations.
- Company typePrivate
- Founded2019
- HeadquartersTokyo, Japan
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Mederi does
Mederi (メデリピル) is a Tokyo-based FemTech company founded in 2019 that operates an online telemedicine platform for women's hormonal health, centered on oral contraceptive prescriptions and obstetrician-gynecologist consultations. The platform connects users with a network of affiliated licensed OB-GYN clinics across Japan via video consultation through LINE, Japan's dominant messaging application, then ships prescribed medications discreetly to home mailboxes in plain packaging labeled as "sundries" (雑貨) via Yamato Transport's Nekopos service, with same-day delivery available within Tokyo's 23 wards. The core product line spans 5 pill categories and 15 formulations — low-dose, ultra-low-dose, medium-dose (period postponement), progestin-only mini-pills, and emergency contraception — priced from ¥2,700/month for low-dose subscriptions up to ¥11,000 per emergency course.
Revenue is generated primarily through recurring pill subscriptions (first month free on low-dose as an acquisition tool), consultation fees (waived for ongoing regular prescriptions, ¥1,650 for medium-dose and emergency consultations), a B2B corporate wellness product (mederi for biz) targeting Japanese company HR departments, and adjacent sub-brands covering skincare (mederi Skin), fertility support (mederi Baby), and STD testing (mederi STD Check Kit). The first-month-free trial, free ongoing consultations, and LINE-native zero-friction booking model all reinforce a product-led growth motion supported by a medically-reviewed content hub (mederi magazine) and community programs (mederi for school, mederi Sports Ambassador). As of September 2024, the platform had dispensed over 1.5 million prescriptions and reported a 98.7% consultation satisfaction rate across 2,193 surveyed members, and in March 2026 the company was named official supplier for Japan's 2027 National Sports Festival in Miyazaki Prefecture.
Mederi firmographics
Firmographics- Name
- Mederi
- Legal name
- mederi Inc. (メデリサイクル)
- Website
- https://mederi.jp
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mederi is a Tokyo-based FemTech company offering online pill prescriptions and obstetrician-gynecologist consultations through a LINE-native telemedicine platform, serving Japanese women with discreet subscription-based hormonal contraceptives and menstrual health treatments across 15 formulations.
- Ownership category
- akta.pro rank
Mederi industry classification
Industry- Product category
- Online Women's Health Telemedicine
- NAICS
- Offices of Physicians (except Mental Health Specialists) (621111), Family Planning Centers (62141), Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Contraception & Family Planning Telehealth (birth control, counseling, follow-up) (HLALAHAB)
- akta.pro secondary industries
- Women’s Health & Contraception Prescribing + Pharmacy Delivery Platforms (HLALAIAI), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ)
Keywords
Where Mederi is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Mederi business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pill prescription sales (subscription): Mederi generates the majority of its revenue from recurring prescription sales of oral contraceptives and related medications. Users subscribe to a regular delivery plan (定期便) and receive medications on a scheduled cycle (typically every 28 days). Revenue is generated per prescription dispensed. The company sources medications from pharmaceutical distributors (Medicio and Alfresa) and ships to end users, retaining the margin between acquisition cost and retail price. Different pill categories carry different price points: low-dose pills are priced at 2,700 yen/month (2,980 yen tax-inclusive) from the second month onward; ultra-low-dose pills range from 4,180 to 9,900 yen; mini-pills start at 4,554 yen/month. The first month of low-dose pill medication is free (with 550 yen shipping), serving as a customer acquisition tool.
- Consultation fees: Mederi charges a consultation fee for certain prescription types. For low-dose, ultra-low-dose, and mini-pills, the consultation fee is free (free for ongoing consultations). However, for medium-dose pills (生理日移動/period postponement) and emergency contraception (アフターピル), a consultation fee of 1,650 yen (tax-inclusive) is charged regardless of whether a prescription is issued. When emergency or medium-dose pills are prescribed simultaneously with a regular (low-dose/super-low-dose/mini) pill, the consultation fee for the emergency/medium-dose pill is waived.
- mederi for biz (corporate wellness): Mederi offers a B2B corporate health support and employee welfare service called 'mederi for biz,' which provides low-dose pill prescriptions and women's health consultations as an employee benefit. Companies pay a subscription or per-employee fee to provide this benefit to female employees. This B2B stream targets Japan's growing corporate wellness market and provides a diversified revenue base alongside the direct-to-consumer business.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Low-dose pills — first month free trial, then 2,700 yen/month subscription |
| Subscription | Monthly | Ultra-low-dose pills — 4,180–9,900 yen/month depending on formulation |
| Unit Pricing | Pay-as-you-go | Medium-dose pills (period postponement) — 1,980–7,920 yen per course |
| Subscription | Multi-year contract | Mini-pill (Slinda) — starting at 4,140 yen/sheet with subscription |
| Unit Pricing | Pay-as-you-go | Emergency contraception (aftersex pill) — 8,950–11,000 yen per course |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Mederi product offering
Product offeringCore offering
Mederi operates an online telemedicine platform (mederi Pill / メデリピル) that connects Japanese women with licensed obstetrician-gynecologists for video consultations via the LINE messaging app, after which physicians issue prescriptions for oral contraceptives (low-dose, ultra-low-dose, medium-dose, emergency, and mini-pill formulations). Prescribed medications are dispensed by affiliated partner pharmacies and shipped directly to users' homes in discreet plain packaging, with same-day delivery available within Tokyo's 23 wards. The service includes free ongoing consultations for routine prescriptions, a free first-month trial for low-dose pills, and a medically-reviewed women's health content platform (mederi magazine).
Product overview
Mederi operates as an online telemedicine platform for women's health, centered around its core service 'mederi Pill' (メデリピル) for online pill consultation and prescription. The platform connects users with obstetricians/gynecologists via video consultation and delivers prescribed medications to homes. Product portfolio includes: core product 'mederi Pill' offering 5 pill categories (低用量ピル/low-dose, 超低用量ピル/ultra-low-dose, 中用量ピル/medium-dose, アフターピル/emergency, ミニピル/mini-pill); corporate wellness service 'mederi for biz'; skincare brand 'mederi Skin'; STD check kit; baby/fertility service 'mederi Baby'; school education program 'mederi for school'; and content platform 'mederi magazine'. Services are accessed primarily through LINE for bookings and video calls for medical consultations.
Differentiator
Problem solved
Functional benefit
Brands
- mederi for biz: Corporate health support and welfare service offering low-dose pill benefits to companies
- mederi for school
- mederi スポーツアンバサダー
- メ德里スキン (mederi Skin)
- メデリバビー (mederi Baby)
- メドリSTDチェックキット (mederi STD Check Kit)
- mederi magazine
Products and services
- mederi Pill (メデリピル) - Online Pill Consultation Service Core online telemedicine service that lets Japanese women consult licensed obstetrician-gynecologists via LINE video call and receive prescriptions for oral contraceptives or related medications delivered to their home in plain packaging. Covers five pill categories with 15 total formulations.
- Low-dose Pills (低用量ピル) Contraceptive pills containing both progesterone and estrogen hormones for contraception, dysmenorrhea relief, PMS management, menstrual regulation, and acne/skin improvement. Available in 5 formulations (Favoir 28, Label Feuille 28, Marvelon 28, Triculer 28, Anju 28) at 2,700 yen/month after a free first month.
- Ultra-low-dose Pills (超低用量ピル) Pills with lower estrogen content than low-dose pills, primarily used for treating dysmenorrhea and endometriosis. Available in 5 formulations (Droethi, Frewell ULD, Lunabell ULD, Yaz, Yazflex) priced from 4,180 yen to 9,900 yen per month.
- Medium-dose Pills (中用量ピル) for Period Postponement Higher-hormone pills used for menstrual cycle manipulation, period postponement/advancement, treatment of abnormal bleeding, amenorrhea, and dysmenorrhea. Sole formulation Pranoval (プラノバール) available in 7, 14, 21, or 28 tablet packs priced 1,980-7,920 yen, plus a 1,650 yen consultation fee.
- Emergency Contraception Pills (アフターピル) Emergency contraception pills taken after contraceptive failure to prevent unwanted pregnancy. Offers a 120-hour effective option (EllaOne, overseas-approved, 8,950 yen) and 72-hour effective options (Norlovo domestically approved at 11,000 yen, Levonorgestrel generic at 9,900 yen), plus a 1,650 yen consultation fee.
- Mini-pill / Progestin-only Pill (ミニピル, Slinda) Progestin-only contraceptive pill (Slinda 28) that contains no estrogen and is associated with lower thrombosis risk. Available on subscription at 4,140 yen/sheet on the 12-sheet bundle (4,554 yen tax-inclusive), with a 3-sheet minimum commitment.
- mederi for biz (Corporate Wellness Program) B2B corporate health support and welfare service that provides low-dose pill prescriptions and women's health consultations as an employee benefit. Targets Japanese companies (sold via dedicated corporate sales team and inquiry form) seeking to add women's health benefits to their employee wellness programs.
- mederi Skin (メデリスキン) Separate skincare product brand under the mederi umbrella, targeted at women and related to the company's women's health positioning.
- mederi STD Check Kit Self-administered STD (sexually transmitted disease) testing kit service that allows users to privately check for sexually transmitted infections as part of the mederi women's health offering.
- mederi Baby (メデリバビー) Baby and fertility support service under the mederi brand, related to women's reproductive health and family planning.
Quantifiable outcome
- 98.7% consultation satisfaction rate (survey of 2,193 members, Jan–May 2024)
- +3 more outcomes
Companies that use Mederi
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
Mederi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Mederi partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and flagship.
- Merone Co., Ltd. (女性の自立支援スクールMerone)coreMederi provides its corporate health support and employee welfare service 'mederi for biz' to Merone Co., Ltd., a women's self-reliance education platform with 2,500 members. Merone conducted a member survey in February 2026 which found that 88% of respondents wanted to acquire correct knowledge about female hormones, 60% wanted to utilize hormone care, but 44% had minimal knowledge about pills — highlighting a significant awareness-access gap. The partnership aims to bridge this gap by providing online hormone consultations and pill prescriptions to support both economic independence and bodily autonomy for women.
- Japan's 2027 National Sports Festival / National Sports Festival for Persons with Disabilities (宮崎県で開催される2027年国民体育大会・全国障害スポーツ大会)flagshipMederi was named an official supplier for Japan's 2027 National Sports Festival (Hinata Miyazaki) and the National Sports Festival for Persons with Disabilities, both to be held in Miyazaki Prefecture. Mederi will provide low-dose pills through its 'mederi Pill' service to female athletes to help manage menstrual and PMS-related health issues that can affect athletic performance. This sponsorship aligns with Mederi's mission to address women's health issues through medicine and technology and represents a significant national-level brand visibility opportunity.
- Meguro Wellness Clinic (目黒ウェルネスクリニック)coreAffiliated medical institution providing online pill consultations and treatments through the Mederi platform. Dr. Watanabe Yuri (渡邉 有里), a board-certified obstetrician-gynecologist and anti-aging specialist, provides online consultations through Mederi and reviews medical content for mederi magazine.
- Kohnotori Ladies Clinic (幸の鳥レディスクリニック)coreAffiliated medical institution providing online pill consultations through the Mederi platform. Dr. Hirano Yumika (平野 友美加), a board-certified obstetrician-gynecologist and perinatal specialist, provides online consultations through Mederi and contributes medical reviews to mederi magazine.
- Nippon Medical School Musashikosugi Hospital (日本医科大学武蔵小杉病院)coreDr. Kaito Yuki (海渡 由貴), Assistant Professor at Nippon Medical School Musashikosugi Hospital's Department of Obstetrics and Gynecology, provides online consultations through Mederi and contributes medical reviews to mederi magazine. Dr. Kaito completed a Doctor of Medical Sciences degree in January 2026.
- Roppongi Ladies Clinic (六本木レディースクリニック)coreDr. Hara Yurie (波羅 友里恵), a board-certified obstetrician-gynecologist at Roppongi Ladies Clinic, provides online consultations through Mederi and contributes medical reviews to mederi magazine. Dr. Hara has personal experience with long-term pill use and egg freezing, enhancing her credibility with patients.
- Yodogawa Christian Hospital (淀川キリスト教病院)coreDr. Shibata Ayako (柴田 綾子), Chief Physician at Yodogawa Christian Hospital's Department of Obstetrics and Gynecology, contributes medical reviews to mederi magazine. Dr. Shibata is a board-certified OB-GYN specialist, perinatal specialist, gender medicine specialist, and travel medicine specialist, lending high medical credibility to the platform's content.
- Seven affiliated OB-GYN physicians (松村 圭子, 郡 詩織, 柴田 綾子, 波羅 友里恵, 海渡 由貴, 平野 友美加, 渡邉 有里)coreMederi's medical review team consists of 7 licensed, board-certified obstetrician-gynecologists who review all mederi magazine content for medical accuracy and safety. They provide online consultations through the platform and participate in public education initiatives. All have completed the Ministry of Health, Labour and Welfare online telemedicine training program. The team includes specialists in reproductive medicine, perinatal care, anti-aging medicine, gender medicine, and oncology.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Mederi competitors and assessment
Company assessmentBroad incumbents
- Wisp: US telehealth provider offering online prescriptions for birth control, emergency contraception, and women's health treatments with home delivery. Comparable in D2C prescription subscription plus discreet delivery model.
- The Pill Club: US online birth control prescription and delivery service, including consultations and ongoing subscription management. Direct international comparable in subscription contraception D2C, useful as a benchmark for global FemTech scale and unit economics.
- Nurx (now part of Thirty Madison): US-based pioneer in online contraception and STI testing, now part of Thirty Madison. Comparable business model (online pill prescription + delivery) and a benchmark for FemTech unit economics in the US, providing international comparability for Mederi's model.
Direct peers
- DMM Online Clinic (DMMオンラインクリニック): DMM's telemedicine arm offering online pill prescriptions alongside other categories like ED and AGA. Backed by DMM's large platform user base and marketing budget, it competes directly for the same Japanese women seeking low-dose pill subscriptions online.
- SmarT Clinic (スマルトクリニック): One of the most prominent Japanese online pill prescription platforms, offering low-dose, ultra-low-dose, and emergency contraception via telemedicine with home delivery. Directly comparable to Mederi across product mix, target demographic, and D2C subscription model.
- YOLO Clinic (YOLOオンラインクリニック): Japanese online clinic specializing in oral contraceptive prescriptions and women's health consultations. Competes directly with Mederi for the same Japanese consumers seeking pill subscription services via telemedicine.
- Pill House (ピルハウス): Japan-based online women's health clinic providing low-dose pill prescriptions and consultations via video. Comparable to Mederi in service scope and target segment, with similar pricing and delivery models.
Emerging players
- Pandia Health: Online women's health platform founded by an OB-GYN, offering birth control prescriptions, auto-refills, and free delivery. Smaller US player but with a comparable physician-led, subscription-based online contraception model.
- LunaLuna (ルナルナ) by MTI: Japan's leading femtech app for menstrual tracking and women's health content, operated by MTI Ltd. While primarily a tracking/content platform, LunaLuna has expanded into online consultations and pill referrals, partially overlapping Mederi's audience and content-to-care funnel.
Regional players
- Oh My Pill (おくすり): Japanese online pill consultation and prescription service targeting women in Japan. Competes with Mederi for the same Japanese consumer base, though generally operating at a smaller scale and brand recognition level.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Mederi social profiles
Digital presenceMederi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mederi leadership team
Management profileNumber of profiles
Profiles1 record
Mederi funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mederi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mederi
What does Mederi do?
Mederi operates an online telemedicine platform (mederi Pill / メデリピル) that connects Japanese women with licensed obstetrician-gynecologists for video consultations via the LINE messaging app, after which physicians issue prescriptions for oral contraceptives (low-dose, ultra-low-dose, medium-dose, emergency, and mini-pill formulations). Prescribed medications are dispensed by affiliated partner pharmacies and shipped directly to users' homes in discreet plain packaging, with same-day delivery available within Tokyo's 23 wards. The service includes free ongoing consultations for routine prescriptions, a free first-month trial for low-dose pills, and a medically-reviewed women's health content platform (mederi magazine).
Is Mederi a public or private company?
Mederi is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mederi founded?
Mederi was founded in 2019. It employs 11 to 50 people.
Where is Mederi based?
Mederi is headquartered in Tokyo, Japan, in the Asia region.
How does Mederi make money?
Three revenue lines are on record. Pill prescription sales (subscription) is the primary driver. The others are consultation fees and mederi for biz (corporate wellness).
Who are Mederi's main competitors?
Broad incumbents on record are Wisp, The Pill Club and Nurx (now part of Thirty Madison). Direct peers are DMM Online Clinic (DMMオンラインクリニック), SmarT Clinic (スマルトクリニック), YOLO Clinic (YOLOオンラインクリニック) and Pill House (ピルハウス). Emerging players are Pandia Health and LunaLuna (ルナルナ) by MTI. Oh My Pill (おくすり) is listed as a regional player.
Does Mederi have an API?
No public API is recorded for Mederi.
What industry is Mederi in?
Mederi's product category is Online Women's Health Telemedicine. Its primary akta.pro industry code is HLALAHAB, Contraception & Family Planning Telehealth (birth control, counseling, follow-up), with a secondary code of HLALAIAI, Women’s Health & Contraception Prescribing + Pharmacy Delivery Platforms. Its NAICS code is 621111 and its SIC code is 8011.